Rigel Pharmaceuticals Inc (RIGL)
1.135
+0.02
(+1.34%)
USD |
NASDAQ |
Apr 23, 16:00
1.135
0.00 (0.00%)
After-Hours: 20:00
Rigel Pharmaceuticals Free Cash Flow (Quarterly): -6.24M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.24M |
| September 30, 2023 | -1.359M |
| June 30, 2023 | 5.93M |
| March 31, 2023 | -19.07M |
| December 31, 2022 | -21.98M |
| September 30, 2022 | -13.49M |
| June 30, 2022 | -12.88M |
| March 31, 2022 | -25.86M |
| December 31, 2021 | -19.06M |
| September 30, 2021 | -10.47M |
| June 30, 2021 | 54.81M |
| March 31, 2021 | -20.03M |
| December 31, 2020 | -16.08M |
| September 30, 2020 | -19.68M |
| June 30, 2020 | -13.99M |
| March 31, 2020 | -3.70M |
| December 31, 2019 | -10.26M |
| September 30, 2019 | -14.99M |
| June 30, 2019 | -16.77M |
| March 31, 2019 | -0.946M |
| December 31, 2018 | 11.58M |
| September 30, 2018 | -20.24M |
| June 30, 2018 | -27.68M |
| March 31, 2018 | -23.59M |
| December 31, 2017 | -19.77M |
| Date | Value |
|---|---|
| September 30, 2017 | -17.67M |
| June 30, 2017 | -19.48M |
| March 31, 2017 | -20.80M |
| December 31, 2016 | -12.47M |
| September 30, 2016 | -22.82M |
| June 30, 2016 | -18.66M |
| March 31, 2016 | -22.74M |
| December 31, 2015 | -13.93M |
| September 30, 2015 | -9.764M |
| June 30, 2015 | -18.22M |
| March 31, 2015 | 17.96M |
| December 31, 2014 | -15.20M |
| September 30, 2014 | -18.34M |
| June 30, 2014 | -20.02M |
| March 31, 2014 | -16.61M |
| December 31, 2013 | -19.07M |
| September 30, 2013 | -20.87M |
| June 30, 2013 | -21.57M |
| March 31, 2013 | -25.79M |
| December 31, 2012 | -22.17M |
| September 30, 2012 | -20.01M |
| June 30, 2012 | -21.56M |
| March 31, 2012 | -24.85M |
| December 31, 2011 | -18.84M |
| September 30, 2011 | -13.35M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-25.86M
Minimum
Mar 2022
54.81M
Maximum
Jun 2021
-9.746M
Average
-13.99M
Median
Jun 2020
Free Cash Flow (Quarterly) Benchmarks
| Nektar Therapeutics | -47.28M |
| Avid Bioservices Inc | -1.224M |
| Stereotaxis Inc | -2.439M |
| Cara Therapeutics Inc | -19.42M |
| Blueprint Medicines Corp | -83.60M |